Published in Hum Genet on September 11, 2014
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network. Clin Pharmacol Ther (2016) 0.86
Whole genome sequencing in pharmacogenomics. Front Pharmacol (2015) 0.80
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine. Paediatr Drugs (2016) 0.75
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther (2011) 10.95
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res (2013) 9.31
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Clinical interpretation and implications of whole-genome sequencing. JAMA (2014) 7.24
Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23
A randomized trial of genotype-guided dosing of warfarin. N Engl J Med (2013) 7.18
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Patterns of linkage disequilibrium in the human genome. Nat Rev Genet (2002) 7.09
PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics (2010) 7.07
Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet (2013) 6.67
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics (2009) 4.31
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther (2012) 4.05
Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin Pharmacol Ther (2012) 3.91
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J (2005) 3.51
Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials. JAMA Intern Med (2014) 3.40
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
Pharmacogenomics and individualized drug therapy. Annu Rev Med (2006) 2.95
Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92
Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA (2001) 2.49
Functional annotation of noncoding sequence variants. Nat Methods (2014) 2.41
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Genome-wide association studies in pharmacogenomics. Nat Rev Genet (2010) 2.14
The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformatics (2012) 1.97
Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review. Ann Intern Med (2011) 1.81
PharmGKB: the Pharmacogenomics Knowledge Base. Methods Mol Biol (2013) 1.81
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol (2010) 1.66
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol (2008) 1.49
Cancer pharmacogenomics: early promise, but concerted effort needed. Science (2013) 1.48
Pharmacogenomics: candidate gene identification, functional validation and mechanisms. Hum Mol Genet (2008) 1.41
Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet (2012) 1.41
MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing. Genome Biol (2014) 1.32
Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics (2013) 1.30
Genetic testing clamp down. Nat Biotechnol (2010) 1.26
In silico pharmacogenetics of warfarin metabolism. Nat Biotechnol (2006) 1.25
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin Genet (1999) 1.23
Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clin Cancer Res (2008) 1.20
In silico and in vitro pharmacogenetic analysis in mice. Proc Natl Acad Sci U S A (2007) 1.17
The European Bioinformatics Institute's data resources 2014. Nucleic Acids Res (2013) 1.17
The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum Genet (2012) 1.16
Improving the prediction of pharmacogenes using text-derived drug-gene relationships. Pac Symp Biocomput (2010) 1.15
PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum Mutat (2008) 1.11
Pharmacogenomic genome-wide association studies: lessons learned thus far. Pharmacogenomics (2009) 1.08
Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer. Br J Clin Pharmacol (2014) 1.06
Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annu Rev Pharmacol Toxicol (2011) 1.03
Characterizing genetic variants for clinical action. Am J Med Genet C Semin Med Genet (2014) 1.02
Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol (2013) 0.98
Milestone approval lifts Illumina's NGS from research into clinic. Nat Biotechnol (2014) 0.97
The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. Genome Med (2013) 0.95
Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration. Pharmacotherapy (2011) 0.92
The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. Thyroid (2010) 0.92
Clinical pharmacogenomics: opportunities and challenges at point of care. Clin Pharmacol Ther (2012) 0.91
Pharmacogenetics of warfarin: challenges and opportunities. J Hum Genet (2013) 0.87
PharmGKB summary: tamoxifen pathway, pharmacokinetics. Pharmacogenet Genomics (2013) 0.85
Prediction of functional regulatory SNPs in monogenic and complex disease. Hum Mutat (2011) 0.85
Getting ready for the Human Phenome Project: the 2012 forum of the Human Variome Project. Hum Mutat (2013) 0.82
A guide to the current Web-based resources in pharmacogenomics. Methods Mol Biol (2013) 0.81
Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional. Pharmacogenomics (2013) 0.79
Translating pharmacogenomics discoveries into the clinic: an implementation framework. Genome Med (2013) 0.77
[Pharmacogenetics: current state after 30 years of research]. Dtsch Med Wochenschr (2013) 0.76